Publications by authors named "Mead Over"

Claim this Profile
R
Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.
Daniel T Halperin, Norman Hearst, Stephen Hodgins, Robert C Bailey, Jeffrey D Klausner, Mead Over

BMC Public Health· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metrics and benchmarks for HIV transition.
Peter D Ghys, Mead Over, Timothy B Hallett, Mary Mahy, Peter Godfrey-Faussett

Lancet HIV· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic returns of ending the AIDS epidemic as a public health threat.
Erik Lamontagne, Mead Over, John Stover

Health Policy· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological metrics and benchmarks for a transition in the HIV epidemic.
Peter D Ghys, Brian G Williams, Mead Over, Timothy B Hallett, Peter Godfrey-Faussett

PLoS Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutual HIV status disclosure is associated with consistent condom use in public sector ART clients in Free State province, South Africa: a short report.
Frederik le Roux Booysen, Edwin Wouters, Damien de Walque, Mead Over

AIDS Care· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
Evelinn Mikkelsen, Jan A C Hontelez, Maarten P M Jansen, Till Bärnighausen, Katharina Hauck, Mead Over

PLoS Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
Elya Tagar, Maaya Sundaram, Kate Condliffe, Blackson Matatiyo, Frank Chimbwandira, Mead Over

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortality.
Matthew Fox, Owen McCarthy, Mead Over

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.
Elliot Marseille, Mark J Giganti, Albert Mwango, Angela Chisembele-Taylor, Lloyd Mulenga, Mead Over

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.
Gesine Meyer-Rath, Mead Over

PLoS Med· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can cost studies improve the performance of donor-financed HIV treatment?
Damian G Walker, Mead Over, Stefano M Bertozzi

AIDS· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health. Global HIV/AIDS policy in transition.
John Bongaarts, Mead Over

Science· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
Elliot Marseille, Lalit Dandona, Nell Marshall, Paul Gaist, Sergio Bautista-Arredondo, Mead Over

BMC Health Serv Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economics of effective AIDS treatment in Thailand.
Mead Over, Ana Revenga, Emiko Masaki, Wiwat Peerapatanapokin, Julian Gold

AIDS· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
Ramanan Laxminarayan, Mead Over, David L Smith

Health Aff (Millwood)· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
Mead Over, Elliot Marseille, Kurapati Sudhakar, Julian Gold, Indrani Gupta

Sex Transm Dis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India.
Lalit Dandona, Pratap Sisodia, T L N Prasad, Elliot Marseille, M Chalapathi Rao, Mead Over

BMC Health Serv Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project.
Elliot Marseille, Lalit Dandona, Joseph Saba, Coline McConnel, Brandi Rollins, Mead Over

Health Serv Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impregnated nets or ddt residual spraying? Field effectiveness of malaria prevention techniques in solomon islands, 1993-1999.
Mead Over, Bernard Bakote'e, Raman Velayudhan, Peter Wilikai, Patricia M Graves

Am J Trop Med Hyg· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation.
Mead Over, Peter Piot

J Infect Dis· October 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis